drugset / Trial / NCT05551182
Nicergoline Use in Dysphagia Patients
Phase 3
Completed
92 enrolled
Phramongkutklao College of Medicine and Hospital
Silpakorn University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Dysphagia is a complication in patient with stroke, Parkinson's disease or dementia that can lead to aspiration pneumonia. This study aimed to investigate dysphagia improvement after treatment with nicergoline low dose and high dose, the relationship between nicergoline dose and clinical improvements, side effect of nicergoline and simulation optimal nicergoline dose in dysphagia improvement.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2025-07-31
- Completion
- 2025-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicergoline | Small molecule | 10 mg | — |
| Subject | Nicergoline | Small molecule | 30 mg | — |
Indications
No indication recorded.